Signaling adaptor protein Crk regulates cell motility and growth through its targets Dock180 and C3G, those are the guanine-nucleotide exchange factors (GEFs) for small GTPases Rac and Rap, respectively. Recently, overexpression of Crk has been reported in various human cancers. To define the role for Crk in human cancer cells, Crk expression was targeted in the human ovarian cancer cell line MCAS through RNA interference, resulting in the establishment of three Crk knockdown cell lines. These cell lines exhibited disorganized actin fibers, reduced number of focal adhesions, and abolishment of lamellipodia formation. Decreased Rac activity was demonstrated by pull-down assay and FRET-based timelapse microscopy, in association with suppression of both motility and invasion by phagokinetic track assay and transwell assay in these cells. Furthermore, Crk knockdown cells exhibited slow growth rates in culture and suppressed anchorage-dependent growth in soft agar. Tumor forming potential in nude mice was attenuated, and intraperitoneal dissemination was not observed when Crk knockdown cells were injected into the peritoneal cavity. These results suggest that the Crk is a key component of focal adhesion and involved in cell growth, invasion, and dissemination of human ovarian cancer cell line MCAS.
Introduction
The regulation of cell motility is a well-organized process in which cells receive information from the surrounding environment through the extracellular matrix (ECM) (Gumbiner, 1996; Lauffenburger and Horwitz, 1996; Sheetz et al., 1998) . Cell surface receptor molecules for the ECM, such as integrins, transmit signals to the actin cytoskeleton through the focal adhesion complex (Brugge, 1998; O'Neill et al., 2000) . Tyrosine kinases, such as focal adhesion kinase (FAK) or proline-rich tyrosine kinase 2 (PYK2), are activated by the ECM and their substrates, p130
Cas (Crk associated substrate) or paxillin, may play a role in regulation of focal adhesion (Yano et al., 2000; Summy and Gallick, 2003) . Downstream of focal adhesion complexes, the Rho family of small GTPases, including Rho, Rac and Cdc42, regulate the reorganization of actin fibers to form stress fibers, lamellipodia and filopodia, all of which control cell motility (Hall, 1998) . Although the deregulation of focal adhesion complexes may contribute to motility and invasion of tumor cells, the precise mechanism is not well understood.
Signaling adaptor protein Crk (CT10 regulated kinase), which is mostly composed of SH2 (src homology 2) and SH3 domains, was originally isolated as an avian sarcoma virus CT10 (chicken tumor 10) encoding oncogene product (Mayer et al., 1988) . Since the isolation of mammalian homologues of viral Crk, such as c-Crk-I and c-Crk-II (Matsuda et al., 1992b) , Crk has been shown to transmit signals under various stimuli including epidermal growth factor, neurotrophic growth factor and fibroblast growth factor (Tanaka et al., 1993; Feller, 2001 ). c-Crk-II possesses one SH2 domain at the N-terminus and two SH3 domains, wheras its alternative splicing product c-Crk-I is composed of the SH2 domain and a single SH3 domain. The SH2 domain is responsible for binding to the tyrosine phosphorylated form of 130
Cas and paxillin, suggesting a role for Crk in regulation of the cytoskeleton (Feller, 2001) . In fact, Crk has been shown to transmit signals to small GTPases by association with its downstream effectors such as Dock180 and C3G, which are the guanine-nucleotide exchange factors (GEFs) for Rac and Rap, respectively (Tanaka et al., 1994; Gotoh et al., 1995; Hasegawa et al., 1996; Kiyokawa et al., 1998) . The activation of Rho was also reported (Tsuda et al., 2002; Iwahara et al., 2003) . Dock180 and its binding molecule ELMO cooperatively regulate Rac activity and are thought to be involved in the phagocytosis of apoptotic cells (Albert et al., 2000; Gumienny et al., 2001; Brugnera et al., 2002) . C3G regulates the MAP kinase and JNK pathway by activating Rap and R-Ras, respectively, following phosphorylation on tyrosine residue 504 (Tanaka et al., 1997; Tanaka and Hanafusa, 1998; Mochizuki et al., 2000) . Studies in C3G knockout mice suggested a role for C3G in the control of cell adhesion (Ohba et al., 2001) .
The contribution of c-Crk to tumorigenesis was suggested by an earlier study showing that c-Crk-I induced anchorage-independent growth of rodent fibroblasts together with tyrosine-phosphorylation of p130 Cas (Matsuda et al., 1992b) . We previously reported that Crk is overexpressed in human cancers including various carcinomas and sarcomas (Nishihara et al., 2002c) . In addition, there are several reports describing overexpression of c-Crk-I in malignant brain tumors and lung cancers (Miller et al., 2003; Takino et al., 2003) . Because ovarian cancer possesses prominent metastatic potential in general and frequently exhibit intraperitoneal dissemination in patients, the human ovarian cancer cell line MCAS provides an appropriate model system to study the role of Crk in tumorigenesis (Judson et al., 1999; Chen et al., 2001) .
In Crk knockdown MCAS cells, disorganization of actin cytoskeleton and decrease of Rac activity was observed. Cell motility and invasion were also decreased in addition to the growth suppression. Crk knockdown MCAS cells lost the ability of intraperitoneal dissemination in mice. These results suggest that Crk may be involved in malignant feature of human ovarian cancer cell line MCAS.
Results

Association of Crk and its targets in MCAS cells
Because both p130
Cas and paxillin are major targets of the SH2 domain of Crk, the tyrosine-phosphorylation status of these proteins was examined in MCAS cells. Immunoprecipitation analysis demonstrated that p130
Cas and paxillin were significantly tyrosine-phosphorylated (Figure 1a) , and their association with Crk was clearly demonstrated (Figure 1b) . We also analysed the association of Crk and its well-known downstream effectors, including Dock180, C3G, Sos and c-Abl, by GST pull-down assay. GST-Crk-I, GST-Crk-II and GST-Crk-SH3(N) associated with these molecules in MCAS cell lysates, whereas GST alone or GST-SH2 did not (Figure 1c ).
Establishment of Crk knockdown MCAS cell lines and morphological analysis
To reduce expression of endogenous Crk in MCAS cells, small interfering RNA (siRNA) was employed. By using Crk siRNA in the pSUPER vector, we successfully established three independent Crk knockdown MCAS cell lines, which were designated Crki-1, Crki-2 and Crki-3. In all three cell lines, the expression of c-Crk-I was completely suppressed (Figure 2A ). The expression of c-Crk-II was significantly decreased in Crki-1 and Crki-2 cells, whereas it was slightly suppressed in Crki-3 cells (Figure 2A ). Endogenous protein levels of CrkL were unchanged as were those of actin ( Figure 2A ). The tyrosine-phosphorylation levels of p130
Cas and paxillin seemed to be slightly different but were statistically constant in Crk knockdown cells ( Figure 2B) .
In MCAS cells, filopodia and lamellipodia were readily identified at the cell edge ( Figure 2C ). In contrast, Crk knockdown cells tended to form small clusters, and the thin cytoplasmic edge found in control MCAS cells was not observed in Crk knockdown cells in phase contrast microscopical analysis ( Figure 2C ). Actin 
Role for Crk in ovarian cancer cells H Linghu et al
staining demonstrated that dense actin bundles were present at the edge of the cytoplasm in Crk knockdown cells, and no lamellipodia was observed ( Figure 2C ). Immunofluorescence using antiphosphotyrosine and antipaxillin antibodies showed that the number of focal adhesions was significantly decreased in Crk knockdown cells ( Figure 2D ). Suppression of lamellipodia formation was confirmed by the transient transfection of the GFP fusion form of actin followed by time-lapse microscopy ( Figure 2E and Supplementary data 1). Thirty-minute observations of single GFP-actin transfected cells showed that Crk knockdown cells can still move, even in the absence of lamellipodia ( Figure 2E and Supplementary data 1 and 2). However, after 3 h of serum stimulation, cell scattering was much more prominent in control MCAS cells than in Crk knockdown cells ( Figure 2F ). To confirm the contribution of Crk to focal adhesion formation, we transiently transfected a expression plasmid for c-Crk-I fused to red fluorescent protein (RFP). Re-expression of c-Crk-I resulted in a recovery of the number of focal adhesions and also lamellipodia formation ( Figure 2G and Supplementary data 3 and 4). It should be noted that in contrast to the RFP-Crk-I, we failed to transiently express RFP-Crk-II with unknown reason (data not shown). Thus, we reexpressed myc-tagged Crk-I or Crk-II in Crk knockdown MCAS cells, and found recovery of lamellipodia both by Crk-I and Crk-II ( Figure 2H ).
Analysis of Rac activity by pull-down assay and FRET-based time-lapse analysis
As Crk is known to regulate Rac through Dock180, we examined the activity of Rac. Consistent with the disappearance of lamellipodia, the amount of activated form of Rac was decreased in three Crk knockdown cells as determined by pull-down assay (Figure 3a) . The decrease of Rac activity seemed to be correlated to the knockdown levels of Crk-II. To confirm the decrease of Rac activation, we utilized FRET-based time-lapse analysis for monitoring the activity of Rac (Itoh et al., 2002) . Positive signals were observed after serum stimulation in control cells, but not in Crk knockdown cells (Figure 3b and Supplementary data 5 and 6).
Analysis of motility, invasion, adhesion and matrix production of Crk knockdown cells To clarify the effect of Crk on cell motility, a phagokinetic track assay was performed. Significantly decreased motilities of Crk knockdown cells were observed in all three Crk knockdown MCAS cells (Figure 4a ). Furthermore, Crk knockdown resulted in a marked suppression of cellular invasion as was determined by a transwell assay ( Figure 4b ). As C3G was reported to regulate cell adhesion (Ohba et al., 2001) , an in vitro adhesion assay was performed. Only Crki-1 cells, Anchorage-dependent and -independent growth of cells As c-Crk has been shown to upregulate cell growth (Matsuda et al., 1992a) , we examined the role for Crk in growth of MCAS cells. Compared to parental cells and control cells, growth rates of three Crk knockdown cells were diminished when grown on non-coating culture plates ( Figure 5a ). We next examined the anchorageindependent growth of these cells by soft agar colonyforming assay. The numbers of medium sized colonies, 1.0-2.0 mm in diameter, were considerably decreased in all three of Crk knockdown cell lines (Figure 5b ). Furthermore, large colonies, more than 2.0 mm in diameter, were detected in wild type and control cells, but not in Crk knockdown cells (Figure 5b ). In contrast, the numbers of small sized colonies, 0.5-1.0 mm in size, were increased in Crk knockdown cells (Figure 5b ).
Tumor formation assay in nude mice
Finally, we investigated the tumor-forming potential of Crk knockdown cells in nude mice. Three weeks after injection of cells, control MCAS cells formed tumors with 14 Â 10 Â 10 mm 3 in size and 0.8 g in weight on average. However, smaller sized tumors, with mean volumes of 10 Â 6 Â 5 mm 3 and mean weight of 0.4 g, were observed following injection with Crk knockdown cells (Table 1 and Figure 6a ). Histopathological analysis demonstrated that control cells formed tumors with necrosis both in center and peripheral area of the tumor nodules (Table 1 and Figure 6b and c) . Tumors formed by Crk knockdown cells exhibited central necrosis, but no small necrotic focus was observed in the peripheral area of the tumor (Figure 6b and c) . Although the MCAS cell line was established from a surgical specimen of mucinous adenocarcinoma, the tumors formed in nude mice did not exhibit prominent mucous secretion. In contrast, in tumors formed by Crk knockdown cells, tubular formation was remarkable and significant mucous production was demonstrated by both of hematoxylin and eosin (H&E) and periodic acid Schiff (PAS) staining (Figure 6d) .
We also injected established cell lines in the peritoneal cavity of nude mice and examined the potential of tumor growth as peritonitis carcinomatosa, which is one of the characteristic features of human ovarian cancer. Autopsy demonstrated that small nodules, 1.0-5.0 mm in size, were disseminated in the peritoneal cavity of mice injected with control cells (Table 1) . Microscopically, tumor cells had invaded into the retroperitoneum with remarkable lymphatic vessel infiltration of the peritoneal wall (Figure 6e ). In contrast, there was no evidence of tumor growth in mice injected with Crk knockdown cells (Figure 6e ).
Discussion
Despite recent advancements in cancer therapy, aggressive tumors, characterized by invasion and metastasis, are still associated with poor prognosis. Among the most highly invasive human cancers, ovarian cancer, especially mucinous adenocarcinoma, is distinguishable due to its frequent intraperitoneal dissemination as well as local invasion. To control the dissemination of tumor cells, an understanding of the physiological mechanism of cell movement is important. ECM stimuli-provoked signals are transmitted, by way of cellular surface receptors such as integrins, to downstream effectors such as the Rho family of small GTPases, which play a central role in cell motility. However, regulation of the activity of small GTPases is complex and is still under investigation.
Recently, we and others reported that signaling adaptor protein Crk is overexpressed in human cancers (Nishihara et . Because Crk links the components of focal adhesion and GEFs for small GTPases, including Rho family proteins, overexpression of Crk may be one of the key events leading to the deterioration of cell motility. To define the precise role for Crk in malignancy of human cancers, we employed siRNA to knock down Crk expression in the human ovarian mucinous adenocarcinoma cell line MCAS. When Crk expression was diminished, cells did not form lamellipodia, probably because of the loss of focal adhesion formation as was shown by immunofluorescence study using antipaxillin and antiphosphotyrosine antibodies. Time-lapse analysis for GFP-actin transfected MCAS cells clearly confirmed that Crk knockdown decreased lamellipodia formation. In Crk knockdown cells, Rac activity was decreased and the motility and invasion potentials were also disturbed. These data suggest that Crk bound to Dock180, which is a GEF for Rac, may play a role in the regulation of motility in MCAS cells.
We did not observe compensatory overexpression of CrkL in CrkII knockdown mince (Figure 2a) . By using retroviral insertional mutation technique, CrkII depleted mice were established. In these mice, the protein expression level of CrkI was intact. The authors of this paper did not examine the levels of CrkL (Imaizumi et al., 1999) . Furthermore, in CrkL knockout study, it is described that the expression level of CrkII was not altered in the mice lacking CrkL (Hemmeryckx et al., 2002) . In fact, we have established CrkII knockdown cells by using three human sarcoma cell lines and a glioblastoma cell line, and we did not observe the increase of the levels of CrkL in these cell lines (data not shown).
In general, the major components of focal adhesions have been shown to include talin, vinculin, tensin, paxillin and p130
Cas . Considering the decrease of the number of focal adhesions in Crk knockdown cells, Crk may be one of the essential components of a certain fraction of focal adhesion complexes. Because the focal adhesions still presented at the border of the cytoplasm in Crk knockdown cells, Crk may not be required to maintain the focal adhesions, at least, located at the cytoplasmic edge.
As C3G and Rap1 have been shown to regulate cell adhesion, we analysed the alteration of cell attachment to several ECMs including fibronectin, collagen, laminin and hyarulonic acid. Although, only Crki-1 cells exhibit small reduction of attachment to laminin (Figure 4c) , basically, no significant suppression of attachment for ECMs was observed in Crk knockdown cells. Correlating to these results, Rap-1 activity was also not changed in Crk knockdown MCAS cells, although serum stimulation did not function as positive control for the assay (Figure 4d) . Therefore, at least in MCAS cells, 
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Crk/C3G-dependent Rap activation may not be a major mechanism of control of cell adhesion to ECMs. The reason why the effect of Crk/C3G/Rap1-dependent signaling was not dominantly observed in MCAS cells should be examined in future.
We also analysed the effect of Crk on the growth of MCAS cells, and found that growth rates of Crk knockdown cells were considerably lower than those of control cells. Thus, Crk may control the cell cycle through a C3G/R-Ras/Jun kinase-dependent mechanism, in addition to activating Ras/Erk through Sos (Tanaka et al., 1997; Tanaka and Hanafusa, 1998) . Furthermore, the suppression of anchoragedependent growth of Crk knockdown cells seems to be reasonable because both cell motility and proliferation were downregulated in these cells. Subcutaneous injection of the cells into nude mice supported the in vitro observations suggesting that Crk may play a role in tumor cell growth and invasion. We confirmed that Crk knockdown cells did not exhibit apoptotic phenotype by using TUNEL stain and FACS analysis for cell cycle. It should be noted that Crk-I was clearly diminished in all three Crk knockdown cells, but Crk-II remained at diefferential levels. The decrease of Rac-activity in three Crk knockdown cells seemed to be related to the levels of remained Crk-II. However, there was no significant difference in the suppression of anchorage-dependent and independent growth of three Crk knockdown cells. It should be noted that we have established several Crk knockdown cells by using human sarcoma and brain tumor cell lines in which Crk-II remained differentially. But in all of the Crk knockdown cell lines, significant decrease of cell growth was observed (T Watanabe, L Wang and S Tanaka, in preparation).
Histopathological analysis showed that reduction of Crk expression enhanced the mucous production of cells. In culture, Crk knockdown cells exhibited matrix production as was demonstrated by the particle exclusion assay. Cells stained positive for PAS, implying that such matrix contains mucin, which may be indicative of cell differentiation. Together with the report that Crk has been shown to be overexpressed in tumor cells with poor prognosis (Miller et al., 2003) , these results suggested that eliminated Crk expression may induce differentiation in tumor cells.
Intraperitoneal injection of tumor cells resulted in a remarkable difference in tumor formation between control and Crk knockdown cells. Crk knockdown cells did not form any tumors in the peritoneal cavity, while control cells produced tumor nodules with lymphoid vessel infiltration. From these results, the attenuation of cell motility, invasion or adhesion may be critical in the survival and growth of tumor cells in the peritoneal cavity. Alternatively, the production of matrix metalloproteinases (MMPs) may be involved in the tumor forming ability in the peritoneal cavity, because Crk was shown to regulate MMP production in rat fibroblasts 3Y1 cells (Liu et al., 2000) .
The results of this study suggest that Crk may be critical for the malignant potential of MCAS cells, presumably by enhancing tumor cell motility, invasion and dissemination. Therefore, the development of a chemical compound that specifically inhibits the association of SH2 or SH3 domains of Crk to their targets may have therapeutic value in future. 
Materials and methods
Cell lines and antibodies MCAS, a human mucinous cystadenocarcinoma cell line (JCRB0240), was purchased from Health Science Research Resources Bank (HSRRB, Osaka, Japan) and maintained in Dulbecco's modified minimal essential medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 2 mM Lglutamine, and 100 U/ml penicillin and streptomycin. The recombinant antibody (Ab) for phosphotyrosine (RC20H), mouse monoclonal antibody (mAb) for Crk (clone 22) and rabbit polyclonal Abs for p130
Cas (C20) and paxillin, were purchased from Transduction Laboratories (Lexington, KY, USA). Antibodies for C3G (C19), CrkL (C20), and Dock180 (H4) were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Plasmids
The plasmid used for Crk interference, pSUPER (suppression of endogenous RNA)-Crk-interference (pSUPER-iCrk) with sequence of 5 0 -UGCCUACGACAAGACAGCC-3 0 corresponding to 746-765 bp of human c-Crk-II gene, was described previously . pCXN2-Flag-Crk and pCXN2-FlagCrkL were generated in our laboratory. pGEX-Crk-I, pGEXCrk-II, pGEX-Crk-SH3(N) and pGEX-CRK-SH3(C) were described previously (Tanaka et al., 1993) . pGEX-PAK2-RBD was also described previously (Nishihara et al., 2002b) .
Immunoprecipitation and immunoblotting
Cells were lysed with lysis buffer containing 150 mM NaCl, 10 mM Tris hydrochloride (pH 7.5), 5 mM EDTA, 10% glycerol, 0.5% Nonidet P-40, 1 mM sodium orthovanadate, 1 mM phenylmethylsulfonyl fluoride (PMSF), 50 mM sodium fluoride. Lysates were incubated with antibodies for 1 h at 41C, followed by incubation with protein G-or protein A-sepharose beads (Calbiochem, Darmstadt, Germany) for 1 h at 41C while rotating. Immunoprecipitates were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotted onto PVDF (polyvinylidene fluoride) filter (Immobilon, Millipore Co., Bedford, MA, USA). The filter was blocked with 3% bovine serum albumin and then incubated with primary Abs followed by peroxidase-conjugated secondary Abs. Positive signals were detected by enhanced chemiluminescence system (Amersham Biosciences, Piscataway, NJ, USA) and analysed by LAS-1000 detection system (Fuji Film, Tokyo, Japan). 
Establishment of Crk knockdown MCAS cells
Cells were co-transfected with 3 mg of pSUPER-iCrk and 0.6. mg of pBabe-puro plasmid, followed by selection with 2 mg/ml puromycin containing medium for 2-3 weeks. Colonies were isolated and the expression levels of Crk were analysed by immunoblotting.
Immunofluorescence analysis of the cells Subconfluent cells grown on glass coverslips were fixed with 3.7% formaldehyde in phosphate-buffered saline (PBS) for 15 min and permeabilized with 0.2% Triton X-100 in PBS for 5 min. To visualize actin filaments (F-actin), cells were stained with TRITC-conjugated phalloidine (1 mg/ml) for 30 min and observed under a confocal immunofluorescence microscope (Olympus, Japan). For time-lapse imaging, MCAS cells were transfected with the mammalian expression plasmid pEGFPactin, 36 h later cells were replated onto glass dishes and GFP signal was obtained every 90 min using a time-lapse system (Nippon Roper, Chiba, Japan). Images were analysed using Metamorph software (Molecular Probe, USA).
GST pull-down assay for detection of Crk-binding proteins Cell lysates containing 300 mg of protein were incubated with 20 mg of either GST, GST-CrkI, GST-CrkII, GST-Crk-SH2 or GST-Crk-SH3(N) for 1 h at 41C, followed by incubation with glutathione-sepharose beads (Amersham Bioscience, Piscataway, NJ, USA) for 1 h at 41C while rotating. Proteins bound to the beads were analysed by immunoblotting.
Pull-down assay for Rac1 activity Detection of the GTP-bound form of Rac1 was performed as described previously (Nishihara et al., 2002a) . Cells were lysed with buffer containing 25 mM HEPES (pH 7.4), 150 mM NaCl, 10% glycerol, 1 mM EDTA, 1% NP40, 10 mM MgCl 2 , 1 mg/ml aprotinin and 1 mM PMSF. Lysates were centrifuged at 12 000 r.p.m. at 41C for 1 min, and the supernatants were incubated with 10 mg of purified GST-PAK2-RBD and glutathione-Sepharose 4B beads. The resulting precipitants were analysed by immunoblotting with anti-Rac1.
FRET-based analysis of Rac activity pRachu-Rac-CAAX was transfected into MCAS cells, and 30 h later cells were cultured in DMEM with 2% FBS for 8 h. After 10% FBS stimulation, FRET-based analysis of Rac activity was performed following the methods established by Dr M Matsuda (Osaka University, Japan) (Itoh et al., 2002) .
Phagokinetic track assay
To analyse cell motility, 2 Â 10 3 cells in DMEM were spread on 24 Â 24 mm 2 coverslips precoated with 1% BSA and colloidal gold particles. After incubating for 24 h, cells were fixed with 3.5% formaldehyde, and the phagokinetic range for each cell was measured using Image Gauge software (Fuji Film, Tokyo, Japan).
Adhesion assay
For analysis of adhesion, 4 Â 10 4 cells were suspended in 0.1 ml of DMEM, plated on 96-well plates, and incubated for 1 h at 371C. The bound cells in each well were lysed, stained with 0.1% crystal violet, and quantified by spectrophotometer at OD A590 nm.
Invasion assay
The lower surface of the filter Bio Coat Matrigel Invasion Chamber (BD Biosciences, Franklin Lakes, NJ, USA) was coated with 1 mg of collagen. Fifty thousands cells were seeded in the upper chambers (24-well chambers) in 0.5 ml of serumfree medium containing 0.01% BSA and 3.3 mM glucose, and the bottom chambers contained the appropriate medium with 1% FBS as a chemo-attractant. The non-invading cells on the upper surface of the filters were removed by wiping with a cotton swab. Cells at the bottom side of the membranes were fixed with ethanol, and stained with 0.5% methyl blue. The number of cells invading through the matrigel membrane was counted in microscopic fields at Â 200 magnification. To minimize the bias, at least three randomly selected fields were counted. Data were averages of triplicate determinants for each condition.
Measurement of growth rates
To measure growth rates, 1 Â 10 5 cells were seeded onto 60-mm diameter plates with DMEM containing 10% FBS, and the numbers of cells were counted everyday using a hemocytometer (Fisher Scientific).
Colony formation assay
To analyse the anchorage-independent growth of cells, 1 Â 10 4 of cells were plated in 60-mm diameter plates with 3 ml of 0.4% noble agar in DMEM in 10% FBS, overlaying 5 ml of 0.5% bacto agar in DMEM with 10% FBS. Colonies were scored 3 weeks after plating. The number of colonies larger than 5 mm in diameter was counted under a microscope.
In vivo tumor formation assay in nude mice MCAS-Crki-1 cell line, in which the expression levels of both c-Crk-I and c-Crk-II was most efficiently suppressed among three established clones (Figure 2a) , were injected into mice. Subcutaneously or intraperitoneally, 1 Â 10 6 cells were injected into three of the 6-week-old female nude mice, BALB/cA Jclnu (nu/nu) (CLEA Japan Inc., Japan). The mice were euthanized 21-24 days after injection, and tumors were removed and weighed. A histopathological examination was performed, including hematoxylin and eosin stain and periodic acid Schiff stain.
